Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor

Blood

Volumn 87, Issue 12, 1996, Pages 5232-5241

  Jadus, Martin R ^a   Irwin, Melanie C N ^b   Irwin, Michael R ^b   Horansky, Robert D ^b   Sekhon, Sant ^b   Pepper, Karen A ^b   Kohn, Donald B ^b   Wepsic, H Terry ^b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; RECOMBINANT COLONY STIMULATING FACTOR 1; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; DOSE RESPONSE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; TUMOR CELL;

EID: 0029950769     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5232.bloodjournal87125232     Document Type: Article

References (58)

1. Fidler IJ: Macrophages and metastasis- a biological approach to cancer therapy: Presidential address. Cancer Res 45:4714, 1985
2. Fidler IJ, Barnes Z, Fogler WE, Kirsch R, Bugelski P, Poste G: Involvement of macrophages in eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res 42:496, 1982
3. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13:265, 1992
4. Klein E, Mantovani A: Action of natural killer and macrophages in cancer. Curr Opin Immunol 5:714, 1993
5. Russell SW, Doe WF, McIntosh AT: Functional characterization of a stable nonlytic stage of macrophage activation in tumors. J Exp Med 146:1511, 1977
6. Adams DO, Marino PA: Evidence for a multistep mechanism of cytolysis by BCG activated macrophages: The interrelationship between the capacity for cytolysis, target binding and secretion of cytolytic factor. J Immunol 126:981, 1981
7. Pace JL, Russell SW, Torres BA, Johnson HM, Gray PW: Recombinant mouse interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol 130:2011, 1983
8. Young DA, Lowe LD, Clark SC: Comparison of the effects of IL3, granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor in supporting monocyte differentiation in culture. J Immunol 145:607, 1990
9. Hori K, Ehrke MJ, Mace K, Maccubbin D, Doyle MJ, Otsuka Y, Mihich E: Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity. Cancer Res 47:2793, 1987
10. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC: Macrophage colony stimulating factor enhances monocyte and macrophage antibody dependent cell mediated cytotoxicity. Cell Immunol 119:182, 1989
11. Wing EJ, Ampel NM, Waheed A, Shadduck RK: Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 135:2052, 1985
12. Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K: Enhancing effect of human monocytic colony stimulating factor on monocyte tumoricidal activity. Cancer Res 49:5013, 1989
13. Feinman R, Henriksen-De Stephane D, Tsujimoto M, Vilcek J: Tumor necrosis factor is an important mediator of tumour cell killing by human monocytes. J Immunol 138:635, 1987
14. Munn DH, Cheung NKV: Phagocytosis of tumor cells by human macrophages cultured in recombinant macrophage colony stimulating factor. J Exp Med 172:231, 1990
15. Green SJ, Chen TY, Crawford RM, Nacy CA, Morrison DC, Meltzer MS: Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-γ monoclonal antibodies against the 73-kda lipopolysaccharide receptor. J Immunol 149:2069, 1992
16. Martin JHJ, Edwards SW: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. J Immunol 150:3478, 1993
17. Drapier JC, Hibbs JB: Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140:2829, 1988
18. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ: Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83:9739, 1986
19. Cerreti DP, Wignall J, Anderson D: Human macrophage colony stimulating factor: Alternative RNA and protein processing from a single gene. Mol Immunol 25:277, 1988
20. Stanley ER: Colony stimulating factor-1, in Aggrawal BB, Gutterman GU (eds): Human cytokines. Boston, MA, Blackwell Scientific, 1991, p 196
21. Stein J, Borzillo GV, Rettenmier CW: Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by plasma membrane-bound precursor of human CSF-1. Blood 76:1308, 1990
22. Nikcevich DA, Young MR, Ellis NK, Newby M, Wepsic HT: Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis. J Immunopharmacology 8:299, 1986
23. Nikcevich DA, Duffle GP, Young MR, Ellis NK, Kaufman GE, Wepsic HT: Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57BL/6 mice. Cell Immunol 109:349, 1986
24. Jadus MR, Irwin MR, Barton BE, Irwin MN, Wepsic HT: The identification of the neonatal NBXFO hybridoma cell and its mediator. Dev Comp Immunol 19:261, 1995
25. Nolta JA, Hanle MB, Kohn DB: Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long lived progenitors. Blood 83:3041, 1994
26. Nolta JA, Yu XJ, Bahner I, Kohn DB: Retroviral mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow. J Clin Invest 90:343, 1992
27. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
28. Markowitz D, Goff S, Bank A: A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J Virol 62:1120, 1988
29. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
30. Krahenbuhl JL, Remington JS: The role of activated macrophages in specific and non-specific cytostasis of tumor cells. J Immunol 113:507, 1983
31. 3H-thymidine release, in Herscowitz HB, Holden HT, Bellanti JA, Ghaffar (eds): Manual of Macrophage Methodology. New York, NY, Marcel Dekker, 1981, p 329
32. Jadus MR, Schmunk G, Djeu J, Parkman R: Morphology and lytic mechanism of interleukin-3 dependent natural cytotoxic cells: Tumor necrosis factor as a possible mediator. J Immunol 137:2774, 1986
33. Jadus MR, Good RW, Crumpacker DB, Yannelli JR: The effects of interleukin 4 upon human tumoricidal cells obtained from patients bearing solid tumors. J Leukoc Biol 49:139, 1991
34. Ramakrishnan S, Xu FJ, Brandt J, Niedel JE, Bast RC, Brown EL: Constitutive production of macrophage colony stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 83:921, 1989
35. Kacinski BM: CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27:79, 1995
36. Chambers SK, Wang Y, Gertz RE, Kacinski BM: Macrophage colony stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 55:1578, 1995
37. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L, Tang R, Fouillait P, Lidereau R: Anti-colony stimulating factor-1 antibody staining in primary breast adenocarcinomas correlated with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86:120, 1994
38. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER, Rohrschneider LR: FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinoma in vivo and in vitro. Oncogene 6:941, 1991
39. Bottazzi B, Erba E, Nobili N, Fazioli F, Rambaldi A, Mantovani A: A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J Immunol 144:2409, 1990
40. Erroi A, Sironi M, Chiaffarino F, Zhen-Guo C, Mengozzi M, Mantovani A: IL1 and IL6 release by tumor associated macrophages from human ovarian carcinoma. Int J Cancer 44:795, 1989
41. Brocker EB, Zwadlo G, Suter L, Brune M, Sorg C: Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. Cancer Immunol Immunother 25:81, 1987
42. Mussoni L, Riganti M, Acero R, Erroi A, Conforti G, Mantovani A, Donati MB: Macrophages associated with murine tumours express plasminogen activator activity. Int J Cancer 41:227, 1988
43. Jadus MR, Sekhon S, Barton BE, Wepsic HT: Macrophage colony stimulating factor activated bone marrow macrophages suppress lymphocytic responses through phagocytosis: A tentative in vitro model of Rosai-Dorfman Disease. J Leukoc Biol 57:936, 1995
44. Allen C, Hogg N: Association of colorectal tumor epithelium expressing HLA-D/DR with CD8 positive T cells and mononuclear phagocytes. Cancer Res 47:2919, 1987
45. Gottlinger HG, Rieber P, Gokel JM, Lohe KJ, Riethmuller G: Infiltrating mononuclear cells in human breast carcinoma: Predominance of T4+ mononuclear cells in the tumor stroma. Int J Cancer 35:199, 1985
46. Brocker EB, Zwadlo G, Holzmann B, Macher E, Sorg C: Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer 41:562, 1988
47. Hibbs JB, Lambert LH, Remington JS: Possible role of macrophage mediated nonspecific cytotoxicity in tumor resistance. Nature 235:48, 1972
48. Fidler IJ, Barnes Z, Fogler WE, Kirsch R, Bugelski P, Poste G: Involvement of macrophages in eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res 42:496, 1982
49. Hume DA, Donahue RE, Fidler IJ: The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Cytokine Res 8:69, 1989
50. Cavallo F, Giovarello M, Gulino A, Vacca A, Stoppacciaro A, Modesti A, Forni G: Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by the IL2 gene. J Immunol 149:3627, 1992
51. Pericle F, Giovarello M, Gulino A, Colombo M, Ferrari G, Musiani P, Modesti A, Cavallo F, Forni G: An efficient Th2-type memory follows CD8+ lymphocyte driven and eosinophil mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL4. J Immunol 153:5659, 1994
52. Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulno A, Colombo MP, Dellabona P, Hock H, Blankenstein T, Rosenthal FM, Gansbacher B, Bosco MC, Musso T, Gusella L, Forni G: Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin-2, IL4, IL6, IL7, IL10, GM-CSF, and γ-IFN gene or admixed with conventional adjuvants. Cancer Res 54:6022, 1994
53. Hock H, Dorsch M, Diamantstein T, Blankenstein T: Interleukin-7 induces CD4+ T cell-dependent tumor rejection. J Exp Med 174:1291, 1991
54. Lollini PL, Bosco MC, Cavallo F, De Giovanni C, Giovarelli M, Landuzzi L, Musiani P, Modesti A, Nicoletti G, Palmieri G, Santoni A, Young HA, Forni G, Nanni P: Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene. Int J Cancer 55:320, 1993
55. Blankenstein T, Qin Z, Uberla K, Muller W, Rosen H, Volk HD, Diamantstein T: Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J Exp Med 173:1047, 1991
56. Guo Y, Wu M, Chen H, Wang X, Liu G, Li G, Ma J, Sy MS: Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263:518, 1994
57. Fidler IJ, Schroit AJ: Recognition and destruction of neoplastic cells by activated macrophages: Discrimination of altered self. Biochim Biophys Acta 948:151, 1988
58. Dorsch M, Hock H, Kunzendorf U, Diamantstein T, Blackenstein T: Macrophage colony stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur J Immunol 23:186, 1993